Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway

Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway

Bibliographic Details
Main Authors:	Qing-rong Li, Zhuo Wang, Wei Zhou, Shou-rui Fan, Run Ma, Li Xue, Lu Yang, Ya-shan Li, Hong-li Tan, Qing-hua Shao, Hong-ying Yang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Neural Regeneration Research

Similar Items

Efficacy of Epalrestat, Duloxetine and Epalrestat in Combination with Methylcobalamine in Diabetic Peripheral Neuropathy
by: Abhilash Penchala, et al.
Published: (2016-12-01)

Evaluation of Efficacy and Safety of Epalrestat (150 mg) Compared to Epalrestat (50 mg) in Patients Suffering from Diabetic Peripheral Neuropathy
by: Sachin Devendrarao Shende, et al.
Published: (2018-04-01)

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
by: Wang XT, et al.
Published: (2018-09-01)

Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
by: Sharma S, et al.
Published: (2008-01-01)

Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials
by: Ming Zhao, et al.
Published: (2018-01-01)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
by: Sangeetha Iyer, et al.
Published: (2019-11-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
by: Daiki Umeda, et al.
Published: (2017-07-01)

Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis
by: Xuan Wang, et al.
Published: (2021-07-01)

High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis
by: Hong-xia Xue, et al.
Published: (2015-01-01)

Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation
by: Keisuke Sato, et al.
Published: (2014-01-01)

Assessment of the renal function, peroxidation damage and inflammatory injury after epalrestat combined with alprostadil treatment of early diabetic nephropathy
by: Hai-Xia Li, et al.
Published: (2017-05-01)

PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy.
by: Young Yeon Kim, et al.
Published: (2020-01-01)

PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy
by: Young Yeon Kim, et al.
Published: (2020-01-01)

Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy
by: Md. Mahadhi Hasan, et al.
Published: (2021-02-01)

Charcot neuroarthropathy of the knee due to idiopathic sensory peripheral neuropathy
by: Qian-Hao Yang, et al.
Published: (2019-10-01)

Peripheral Neuropathy
Published: (2014)

Evaluation of renal function and oxidative stress after adjuvant epalrestat treatment of early diabetic nephropathy
by: Ge Zhao, et al.
Published: (2017-04-01)

Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury
by: Heba El Gamal, et al.
Published: (2017-01-01)

CHOP/ORP150 Ratio in Endoplasmic Reticulum Stress: A New Mechanism for Diabetic Peripheral Neuropathy
by: Yuan-Bo Wu, et al.
Published: (2013-08-01)

Berberine Alleviates Paclitaxel-Induced Neuropathy
by: Ramin Rezaee, et al.
Published: (2019-06-01)

Clinical observation on the curative effect of epalrestat combined with compound anisodine in treatment of non-proliferative diabetic retinopathy
by: Xiu-Yun Gao, et al.
Published: (2019-06-01)

Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells
by: Kaori Yama, et al.
Published: (2015-04-01)

Corrigendum to “Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury”
by: Heba El Gamal, et al.
Published: (2019-01-01)

Diagnosis of peripheral neuropathy
by: Helmar C. Lehmann, et al.
Published: (2020-07-01)

Permanent Peripheral Neuropathy
by: Jacquelyn K. Francis BA, et al.
Published: (2014-07-01)

Propylthiouracil and peripheral neuropathy
by: Valentina Van Boekel, et al.
Published: (1992-06-01)

Peripheral neuropathy in thalassaemia
by: Sawaya Raja, et al.
Published: (2006-01-01)

Vasculitic peripheral neuropathy
by: Mona Amini, et al.
Published: (2014-02-01)

Painful peripheral neuropathy
by: Bo SUN, et al.
Published: (2013-09-01)

The genetics of peripheral neuropathy
by: Houlden, Henry James
Published: (2004)

Autophagy in Peripheral Neuropathy
by: Osman, Ayman
Published: (2017)

Peripheral neuropathies of childhood
by: Wilmshurst, Jo
Published: (2014)

Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice.
by: Lei Wang, et al.
Published: (2015-01-01)

The Protective Effect and Mechanism of Dexmedetomidine on Diabetic Peripheral Neuropathy in Rats
by: Yan-zhuo Zhang, et al.
Published: (2020-07-01)

Surgical decompression of painful diabetic peripheral neuropathy: the role of pain distribution.
by: Chenlong Liao, et al.
Published: (2014-01-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
by: Jian-bin Su, et al.
Published: (2018-03-01)

Peripheral Neuropathy Advances in Diagnostic and Therapeutic Approaches
Published: (2012)

Effect of mild moxibustion in improving the quality of life of patients with diabetic peripheral neuropathy
by: Dou-Dou Li, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_mueoe98271om8f62pgb4dsb1k5